Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Ca-Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Ju W, Zheng R, Zhang S, Zeng H, Sun K, Wang S, et al. Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea. Sci China Life Sci. 2023;66(5):1079–91.

Article  PubMed  Google Scholar 

Iglesias-Gato D, Wikstrom P, Tyanova S, Lavallee C, Thysell E, Carlsson J, et al. The Proteome of primary prostate Cancer. Eur Urol. 2016;69(5):942–52.

Article  CAS  PubMed  Google Scholar 

Lima T, Rodrigues JE, Manadas B, Henrique R, Fardilha M, Vitorino R. A peptide-centric approach to analyse quantitative proteomics data- an application to prostate cancer biomarker discovery. J Proteom. 2023;272:104774.

Article  CAS  Google Scholar 

Fu Q, Hong R, Zhou H, Li Y, Liu X, Gong J, et al. Proteomics reveals MRPL4 as a high-risk factor and a potential diagnostic biomarker for prostate cancer. Proteomics. 2022;22(21):e2200081.

Article  PubMed  Google Scholar 

Zhang Y, Wang D, Li M, Wei X, Liu S, Zhao M, et al. Quantitative proteomics of TRAMP mice combined with Bioinformatics Analysis Reveals that PDGF-B Regulatory Network Plays a key role in prostate Cancer progression. J Proteome Res. 2018;17(7):2401–11.

Article  CAS  PubMed  Google Scholar 

Latonen L, Afyounian E, Jylha A, Nattinen J, Aapola U, Annala M, et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. Nat Commun. 2018;9(1):1176.

Article  PubMed  PubMed Central  Google Scholar 

Chen C, Shen H, Zhang LG, Liu J, Cao XG, Yao AL, et al. Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer. Int J Mol Med. 2016;37(6):1576–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Launonen KM, Paakinaho V, Sigismondo G, Malinen M, Sironen R, Hartikainen JM, et al. Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells. Oncogene. 2021;40(27):4567–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen M, Zhu P, Wan Q, Ruan X, Wu P, Hao Y, et al. High-Coverage four-Dimensional Data-Independent Acquisition Proteomics and Phosphoproteomics enabled by deep learning-driven multidimensional predictions. Anal Chem. 2023;95(19):7495–502.

Article  CAS  PubMed  Google Scholar 

Zheng N, Shabek N. Ubiquitin ligases: structure, function, and Regulation. Annu Rev Biochem. 2017;86:129–57.

Article  CAS  PubMed  Google Scholar 

Mevissen TET, Komander D. Mechanisms of Deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159–92.

Article  CAS  PubMed  Google Scholar 

Scher HI, Beer TM, Higano CS, Anand A, Taplin ME, Efstathiou E, et al. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study. Lancet. 2010;375(9724):1437–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shore ND, Chowdhury S, Villers A, Klotz L, Siemens DR, Phung D, et al. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. Lancet Oncol. 2016;17(2):153–63.

Article  CAS  PubMed  Google Scholar 

Wyatt AW, Azad AA, Volik SV, Annala M, Beja K, McConeghy B, et al. Genomic alterations in cell-free DNA and Enzalutamide Resistance in Castration-resistant prostate Cancer. JAMA Oncol. 2016;2(12):1598–606.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Chan SC, Brand LJ, Hwang TH, Silverstein KA, Dehm SM. Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines. Cancer Res. 2013;73(2):483–9.

Article  CAS  PubMed  Google Scholar 

Alumkal JJ, Sun D, Lu E, Beer TM, Thomas GV, Latour E, et al. Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance. Proc Natl Acad Sci U S A. 2020;117(22):12315–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruan H, Bao L, Tao Z, Chen K. Flightless I homolog reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in prostate Cancer. Cancer Immunol Res. 2021;9(7):838–52.

Article  CAS  PubMed  Google Scholar 

Ghildiyal R, Sawant M, Renganathan A, Mahajan K, Kim EH, Luo J, et al. Loss of long noncoding RNA NXTAR in prostate Cancer augments androgen receptor expression and Enzalutamide Resistance. Cancer Res. 2022;82(1):155–68.

Article  CAS  PubMed  Google Scholar 

Cantalapiedra CP, Hernandez-Plaza A, Letunic I, Bork P, Huerta-Cepas J. eggNOG-mapper v2: functional annotation, Orthology assignments, and Domain Prediction at the Metagenomic Scale. Mol Biol Evol. 2021;38(12):5825–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, et al. A Cellular anatomy of the normal adult human prostate and Prostatic Urethra. Cell Rep. 2018;25(12):3530–42. e5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong Q, Sun R, Aref AT, Noor Z, Anees A, Zhu Y et al. Proteomic-based stratification of intermediate-risk prostate cancer patients. Life Sci Alliance. 2024;7(2).

Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20(7):421–35.

Article  CAS  PubMed  Google Scholar 

Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.

Article  PubMed  Google Scholar 

Li J, Smith LS, Zhu HJ. Data-independent acquisition (DIA): an emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters. Drug Discov Today Technol. 2021;39:49–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fagerberg L, Hallstrom BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteom. 2014;13(2):397–406.

Article  CAS  Google Scholar 

Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15(8):457–70.

Article  CAS  PubMed